CYP2C9, CYP2C19, CYP2D6 and CYP3A5 polymorphisms in South‐East and East Asian populations: A systematic review

PW Dorji, G Tshering… - Journal of clinical …, 2019 - Wiley Online Library
What is known and objective Genetic polymorphism is one of the most important factors
responsible for interindividual and interethnic variability in drug response. Studies in major …

CYP2C19 polymorphism in relation to the pharmacotherapy optimization of commonly used drugs

B Sienkiewicz-Oleszkiewicz… - Die Pharmazie-An …, 2018 - ingentaconnect.com
Purpose: The CYP2C19 isoenzyme plays an important role in the efficacy and safe use of
many drugs. The aim of this review is to demonstrate how CYP2C19 mutations influence …

CYP2C19 allele frequencies in over 2.2 million direct‐to‐consumer genetics research participants and the potential implication for prescriptions in a large health …

Y Ionova, J Ashenhurst, J Zhan, H Nhan… - Clinical and …, 2020 - Wiley Online Library
Understanding the prevalence of clinically relevant pharmacogenetic variants using large
unselected populations is critical for gauging the potential clinical impact of widespread …

[HTML][HTML] Analysis of CYP2C19 genetic polymorphism in a large ethnic Hakka population in southern China

Z Zhong, J Hou, B Li, Q Zhang, S Liu, C Li… - … Medical Journal of …, 2017 - ncbi.nlm.nih.gov
Background Cytochrome P450 (CYP) 2C19 is an enzyme involved in the bioactivation of
various important therapeutic drugs, from pro-drugs to an active inhibitor of platelet action …

CYP2C19 genotyping may provide a better treatment strategy when administering escitalopram in Chinese population

X Huang, C Li, C Li, Z Li, X Li, J Liao, T Rao… - Frontiers in …, 2021 - frontiersin.org
Depression disorder is one of the most serious mental illnesses in the world. Escitalopram is
the essential first-line medication for depression disorder. It is the substrate of hepatic …

CYP2C19 gene polymorphism in Ningxia

Z Yang, Y Xie, D Zhang, Y Zou, X Li, R Chen… - Pharmacological …, 2023 - Springer
Background Poor metabolizer (PM) status of CYP2C19 can be a predisposing factor for
developing gastric cancer in H. pylori-infected patients. It is unclear whether PM status of …

Role of genetic polymorphisms in clopidogrel response variability: a systematic review

J Lopez, J Mark, GJ Duarte, M Shaban, F Sosa… - Open …, 2023 - openheart.bmj.com
Introduction Clopidogrel is a P2Y12 inhibitor that has become a mainstay treatment
following percutaneous intervention with drug-eluting stent placement to decrease …

Han Chinese specific cytochrome P450 polymorphisms and their impact on the metabolism of anti-hypertensive drugs with adrenoreceptor blocking properties

JC Qian, JP Cai, GX Hu - Expert Opinion on Drug Metabolism & …, 2021 - Taylor & Francis
ABSTRACT Introduction: Cytochrome P450 (CYP) is a monooxygenase superfamily
mediating the elimination of anti-hypertensive drugs. Polymorphisms of CYP would lead to …

Pharmacogenetic relevant polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 in Bhutanese population

PW Dorji, S Wangchuk, K Boonprasert… - Drug Metabolism and …, 2019 - degruyter.com
Background Marked differences among genotype frequencies (Caucasians, Asians, and
Africans) have been observed in cytochrome P450 (CYP) genes. Data on the frequency of …

[HTML][HTML] Effects of mongolian medicine Terminalia chebula Retz. on 6 CYP450 enzymes in rats

G Wu, Z Dong, J Dong, L Wei, R Shi… - … Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
Terminalia chebula Retz.(TCR) is a medicinal material commonly used in Mongolian
medicine. After consulting the literature at home and abroad, current research on TCR …